Pharmaceutical advertising; prohibiting certain direct-to-consumer advertising; providing civil and criminal penalties. Effective date. Emergency.

Oklahoma's SB 2021 bans pharmaceutical companies from advertising prescription drugs directly to consumers through any medium (including TV, social media, digital platforms, or print) within the state or primarily targeting Oklahoma residents. It exempts healthcare provider educational materials, evidence-based public health campaigns, clinical trial promotions, and insurance coverage information. Companies must submit annual compliance reports to the Attorney General, and violations face tiered penalties: civil fines up to $500,000 for repeated offenses or criminal charges for egregious violations. The law aims to reduce misleading advertising and its impact on prescribing practices, aligning with public health standards used in most other nations.